Dr. Heyne is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6445 Main St
# OPC21
Houston, TX 77030Phone+1 713-441-9948Fax+1 713-441-8791
Education & Training
- Baylor College of MedicineFellowship, Hematology, 1985 - 1988
- Baylor College of MedicineResidency, Internal Medicine, 1984 - 1985
- New York Downtown HospitalResidency, Internal Medicine, 1983 - 1984
- Baylor College of MedicineInternship, Internal Medicine, 1981 - 1982
- Baylor College of MedicineClass of 1981
Certifications & Licensure
- TX State Medical License 1982 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Clinical Trials
- A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinoma Start of enrollment: 2019 Sep 30
Publications & Presentations
PubMed
- 5 citationsTransplant Oncology: An Emerging Discipline of Cancer Treatment.Maen Abdelrahim, Abdullah Esmail, Ala Abudayyeh, Naoka Murakami, David Victor
Cancers. 2023-11-09 - 1 citationsImpact of Infections in Patients Receiving Pembrolizumab-Based Therapies for Non-Small Cell Lung Cancer.Ethan A Burns, Kelly Gee, Ryan B Kieser, Jiaqiong Xu, Yuqi Zhang
Cancers. 2022-12-23 - 19 citationsTransarterial Chemoembolization (TACE) Plus Sorafenib Compared to TACE Alone in Transplant Recipients with Hepatocellular Carcinoma: An Institution Experience.Maen Abdelrahim, David Victor, Abdullah Esmail, Sudha Kodali, Edward A Graviss
Cancers. 2022-01-27
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: